Category: Biohacking

The use of metformin for anti-aging has grown in popularity among some in the biohacking community, but Dave Asprey’s protocol has changed significantly. While he once incorporated the diabetes drug for longevity, the iconic biohacker no longer takes metformin daily due to a specific side effect.

With more than 200 peptides currently in clinical development and hundreds more in preclinical trials, the long-term side effects of peptides remain largely unknown for many compounds, particularly those sourced from unregulated markets.